Literature DB >> 14990542

Mucus observations in the fertile window: a better predictor of conception than timing of intercourse.

Jamie L Bigelow1, David B Dunson, Joseph B Stanford, René Ecochard, Christian Gnoth, Bernardo Colombo.   

Abstract

BACKGROUND: Intercourse results in a pregnancy essentially only if it occurs during the 6-day fertile interval ending on the day of ovulation. The strong association between timing of intercourse within this interval and the probability of conception typically is attributed to limited sperm and egg life times.
METHODS: A total of 782 women recruited from natural family planning centres in Europe contributed prospective data on 7288 menstrual cycles. Daily records of intercourse, basal body temperature and vaginal discharge of cervical mucus were collected. Probabilities of conception were estimated according to the timing of intercourse relative to ovulation and a 1-4 score of mucus quality.
RESULTS: There was a strong increasing trend in the day-specific probabilities of pregnancy with increases in the mucus score. Adjusting for the mucus score, the day-specific probabilities had limited variability across the fertile interval.
CONCLUSIONS: Changes in mucus quality across the fertile interval predict the observed pattern in the day-specific probabilities of conception. To maximize the likelihood of conception, intercourse should occur on days with optimal mucus quality, as observed in vaginal discharge, regardless of the exact timing relative to ovulation.

Entities:  

Mesh:

Year:  2004        PMID: 14990542     DOI: 10.1093/humrep/deh173

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

1.  Joint modeling of intercourse behavior and human fecundability using structural equation models.

Authors:  Sungduk Kim; Rajeshwari Sundaram; Germaine M Buck Louis
Journal:  Biostatistics       Date:  2010-02-19       Impact factor: 5.899

2.  Self-Monitoring of Fertility Hormones: A New Era for Natural Family Planning?

Authors:  Leonard Blackwell; Delwyn Cooke; Simon Brown
Journal:  Linacre Q       Date:  2018-03-28

3.  Physiological signs of ovulation and fertility readily observable by women.

Authors:  Martin Owen
Journal:  Linacre Q       Date:  2013-02

4.  Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive.

Authors:  Emily Evans-Hoeker; David A Pritchard; D Leann Long; Amy H Herring; Joseph B Stanford; Anne Z Steiner
Journal:  Fertil Steril       Date:  2013-07-11       Impact factor: 7.329

5.  Dissociation between Cervical Mucus and Urinary Hormones during the Postpartum Return of Fertility in Breastfeeding Women.

Authors:  Thomas Bouchard; Len Blackwell; Simon Brown; Richard Fehring; Suzanne Parenteau-Carreau
Journal:  Linacre Q       Date:  2018-11-30

6.  Cervical immune activation during the luteal phase may compromise subsequent trans-cervical ram sperm transport†.

Authors:  Laura Abril-Parreño; Anette Kristine Krogenæs; Xavier Druart; Paul Cormican; Sean Fair; Kieran G Meade
Journal:  Biol Reprod       Date:  2022-10-11       Impact factor: 4.161

7.  Genomic Comparisons of Lactobacillus crispatus and Lactobacillus iners Reveal Potential Ecological Drivers of Community Composition in the Vagina.

Authors:  Michael T France; Helena Mendes-Soares; Larry J Forney
Journal:  Appl Environ Microbiol       Date:  2016-11-21       Impact factor: 4.792

8.  Effect of vaginal lubricants on natural fertility.

Authors:  Anne Z Steiner; D Leann Long; Catherine Tanner; Amy H Herring
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

9.  Impact of instruction in the Creighton model fertilitycare system on time to pregnancy in couples of proven fecundity: results of a randomised trial.

Authors:  Joseph B Stanford; Ken R Smith; Michael W Varner
Journal:  Paediatr Perinat Epidemiol       Date:  2014-09       Impact factor: 3.980

Review 10.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.